You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 9 No. 4, October 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Location of Brain Tumors With Polyvinylpyrrolidone-I131

PAUL J. PITLYK, MD; W. NEWLON TAUXE, MD; FREDERICK W. L. KERR, MD; RICHARD E. SEDLACK, MD; HENDRIK J. SVIEN, MD

Arch Neurol. 1963;9(4):437-443.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In recent years, improvements in instrumentation (collimators, mechanical scanning devices, and so forth) and the availability of a greater variety of radioactive isotopes and substances labelled with isotopes have led to renewed optimism regarding the use of scanning methods for locating intracranial tumors. To the clinician these methods represent a valuable adjunct to standard contrast studies, and to the patient, a more tolerable diagnostic procedure.

Various agents, including arsenic, copper, potassium, phosphorus, iodoalbumin, and sodium iodide, have been used, paralleling progressive refinement of detection systems.1-7 However, results have been of limited value, until the recent introduction of chlormerodrin,8 with accuracy remaining considerably below that afforded by the classical contrast studies. Part of the reason for this failure is the accumulation of the tracer agents in muscle, thereby interfering with detection of lesions in the posterior fossa deep to the suboccipital musculature. Also there has been concern about irradiation . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN

Fellow in Neurosurgery, Mayo Foundation (Dr. Pitlyk); Section of Clinical Pathology (Dr. Tauxe), Section of Neurologic Surgery (Dr. Kerr), Section of Medicine (Dr. Sedlack), Section of Neurologic Surgery (Dr. Svien), Mayo Clinic and Mayo Foundation.


Footnotes

Submitted for publication June 5, 1963.

This investigation was supported in part by Research grant B-3296 from the National Institutes of Health, Public Health Service.

Abridgment of thesis submitted by Dr. Pitlyk to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Neurosurgery.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.